• Nigeria launches broad HPV vaccination campaign to combat cervical cancer.
• HPV, commonly spread through intimate contact, can lead to cervical cancer.
• A 2021 study shows the HPV vaccine reduces cervical cancer cases by nearly 90%.

Nigeria has initiated a widespread vaccination initiative targeting the human papillomavirus (HPV) to significantly lower cervical cancer occurrences.

HPV, a prevalent virus often transmitted through intimate sexual contact, can, in a minority of instances, progress to cervical cancer.

In a significant 2021 study, the HPV vaccine was observed to reduce cervical cancer cases by nearly 90%.

Nigeria’s Health Minister Muhammad Pate told the media was vital as “at least 12,000 women every year have advanced stages of cervical cancer [in Nigeria]”.

“About 90% of them lose their lives because of that,” he added.

Commencing this Tuesday, the nationwide campaign aims to vaccinate 16.6 million girls aged nine to 14 by the conclusion of 2025, according to the health ministry.

The effort has been seamlessly incorporated into Nigeria’s national immunization schedule, with engagement extending to collaboration with educational institutions and involvement of leaders from both religious and civil society domains.

[embedpost slug= “israel-hamas-war-gaza-hospitals-in-crisis-collapse-of-healthcare-system/”]

To stay informed about current events, please like our Facebook page https://www.facebook.com/BOLUrduNews/.
Follow us on Twitter https://twitter.com/bolnewsurdu01 and stay updated with the latest news.
Subscribe to our YouTube channel https://bit.ly/3Tv8a3P to watch news from Pakistan and around the world.